- Supported exchanges /
- NSE /
- KILITCH.NSE
Kilitch Drugs (India) Limited (KILITCH NSE) stock market data APIs
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-inflammatory, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, antifungals, corticosteroids, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products. The company also provides a range of oral formulations, including tablets, soft gelatin capsules, dry syrup, gripe water, and oral gel, powder, and liquid in the cardiovascular and anti-diabetics areas. In addition, it offers effervescent tablets and powders, such as ROIPAR, DUREGRA, and ROIVIT; and various nutritional products, such as CELTINE. Further, the company provides C-Seal, a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally, it offers cosmetics and herbal products consisting of a range of oils, creams, lotions, liquids, and paste in skin, personal, and hair care categories, as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes, obesity, libido, and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.
Kilitch Drugs (India) Limited Financial Data Overview
| 307.45 | |
| 311.1 | |
| - | |
| 319.7 | |
| 305.1 | |
| 300-470 | |
| 5 002 M | |
| 30.2824 | |
| 16 082 K | |
| 1 513 M | |
| 0.282 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Kilitch Drugs (India) Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 513 M
- EBITDA 197 M
- Earnings Per Share 10.27
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Kilitch Drugs (India) Limited Earnings via APIs
- Latest Release 2024-11-07
- EPS/Forecast NaN
Get Kilitch Drugs (India) Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
